Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5378178 | 6329400 | I | 5378178-5 | 20070530 | 20070627 | 20070705 | EXP | US-JNJFOC-20070600960 | JOHNSON + JOHNSON PHARMACEUTICAL R+D | F | Y | 79.83 | KG | 20070705 | MD | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5378178 | 1008662146 | PS | PREZISTA | 1 | ORAL | 00108 | 21976 | ||||
5378178 | 1008662147 | SS | PREZISTA | 1 | ORAL | 00108 | 062477 | ||||
5378178 | 1008662148 | SS | RITONAVIR | 2 | UNKNOWN | 40195;40196 | |||||
5378178 | 1008662149 | SS | ETRAVIRINE | 1 | ORAL | 20127 | |||||
5378178 | 1008662150 | C | TRUVADA | 1 | UNKNOWN | 100067 | |||||
5378178 | 1008662151 | C | REYATAZ | 1 | UNKNOWN | ||||||
5378178 | 1008662152 | C | ATRIPLA | 1 | ORAL | ||||||
5378178 | 1008662153 | C | IBUPROFEN | 1 | ORAL | ||||||
5378178 | 1008662154 | C | KEFLEX | 1 | ORAL | ||||||
5378178 | 1008662155 | C | ULTRAM | 1 | ORAL | ||||||
5378178 | 1008662156 | C | LORTAB | 1 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5378178 | 1008662147 | HIV INFECTION |
5378178 | 1008662148 | HIV INFECTION |
5378178 | 1008662149 | HIV INFECTION |
5378178 | 1008662150 | HIV INFECTION |
5378178 | 1008662151 | HIV INFECTION |
5378178 | 1008662152 | HIV INFECTION |
Outcome of event
Event ID | OUTC COD |
---|---|
5378178 | OT |
Reactions reported
Event ID | PT |
---|---|
5378178 | ASPARTATE AMINOTRANSFERASE INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |